June 30, 2008


IDSA Advocacy Update: IDSA Opposes HHS Proposal for Home Stockpiling of Doxycycline


IDSA has urged the Department of Health and Human Services (HHS) to reconsider a proposal to allow home stockpiling of doxycycline to prepare for a potential terrorist anthrax attack.

At a meeting of the National Biodefense Science Board, IDSA delivered public comments raising concerns about the HHS initiative. In the absence of an increased risk of attack, IDSA said, “it is unclear how the potential benefits could outweigh the risks,” including misuse, side effects, and resistance. Furthermore, the Society commented, it is not clear that home stockpiling would significantly improve any federal or local efforts to distribute antibiotics in case of an emergency.

Federal policy on the issue is still evolving, and IDSA will continue to provide input.

Other advocacy items include:

  • IDSA joined over a dozen other public health organizations in signing on to an open letter to congress in support of scientifically valid immunization policies.
  • IDSA joined other global health groups in calling on Congress to significantly increase funding for global health research programs at CDC and NIH, especially at NIAID and the Fogarty International Center.
  • IDSA signed onto a letter urging Medicare to delay implementation of new Medicare released new incident-to billing guidelines which were set to take effect on June 2 until their potential impact could be analyzed in greater detail.


How useful is this article?
< Previous Article | Next Article >

Updated Blastomycosis Guidelines Feature New Treatments
New Pre-pandemic Vaccine Highlights Progress, Raises Questions
IDSA Journal Club, June 2008
In the IDSA Journals
Drug Approvals, Recalls, Adverse Events Update
EIN: What to Do About Hepatitis B Vaccine Non-responders
NIAID Solicits Clinical Trials Proposals to Reduce the Risk of Antimicrobial Resistance
New Coding Resource Helps Clinicians Choose Appropriate Service Codes
CMS Releases Problematic New List of Hospital-acquired Conditions
FDA Moves to Update Antibacterial Breakpoints
IDSA Advocacy Update: IDSA Opposes HHS Proposal for Home Stockpiling of Doxycycline
New Book Addresses Questions about Vaccine Safety
New Desktop Software for Keeping Kids on Track with Immunizations
IDSA Holds First Fellows’ In-Training Exam
Members on the Move
Welcome, New IDSA Members!


Search Back Issues
Forward this Issue
Print-Friendly Version

© Copyright IDSA 2008 Infectious Diseases Society of America 1300 Wilson Boulevard, Suite 300 Arlington, VA 22209 info@idsociety.org

Home Page Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA